Fort Washington Investment Advisors Inc. OH acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) during the 1st quarter, Holdings Channel reports. The fund acquired 189,611 shares of the company’s stock, valued at approximately $3,900,000.
Other institutional investors have also recently bought and sold shares of the company. Royal Bank of Canada increased its stake in Privia Health Group by 63.5% in the first quarter. Royal Bank of Canada now owns 245,633 shares of the company’s stock valued at $5,514,000 after purchasing an additional 95,371 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of Privia Health Group by 24.7% during the first quarter. AQR Capital Management LLC now owns 40,781 shares of the company’s stock worth $916,000 after purchasing an additional 8,068 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Privia Health Group by 3.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 118,764 shares of the company’s stock worth $2,666,000 after purchasing an additional 3,714 shares in the last quarter. Intech Investment Management LLC grew its holdings in shares of Privia Health Group by 55.1% in the 1st quarter. Intech Investment Management LLC now owns 56,553 shares of the company’s stock valued at $1,270,000 after buying an additional 20,082 shares during the period. Finally, Acadian Asset Management LLC acquired a new position in shares of Privia Health Group in the 1st quarter valued at $154,000. Institutional investors and hedge funds own 94.48% of the company’s stock.
Privia Health Group Stock Down 0.1%
NASDAQ:PRVA opened at $25.55 on Tuesday. The company has a market cap of $3.22 billion, a P/E ratio of 159.70, a price-to-earnings-growth ratio of 2.02 and a beta of 0.90. Privia Health Group, Inc. has a twelve month low of $18.77 and a twelve month high of $26.51. The business has a 50 day moving average price of $23.22 and a two-hundred day moving average price of $22.95.
Analysts Set New Price Targets
PRVA has been the subject of a number of recent analyst reports. Truist Financial upped their price objective on shares of Privia Health Group from $31.00 to $33.00 and gave the company a “buy” rating in a research report on Monday, March 2nd. Evercore set a $26.00 target price on Privia Health Group in a report on Wednesday, April 8th. Canaccord Genuity Group decreased their target price on Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, May 8th. Barclays lowered their price target on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a report on Tuesday, May 26th. Finally, Citigroup dropped their price target on Privia Health Group from $34.00 to $32.00 and set a “buy” rating on the stock in a research report on Tuesday, March 3rd. Eleven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Privia Health Group has a consensus rating of “Moderate Buy” and an average target price of $31.15.
Check Out Our Latest Analysis on Privia Health Group
Insider Buying and Selling
In other Privia Health Group news, CFO David Mountcastle sold 7,179 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $25.03, for a total transaction of $179,690.37. Following the sale, the chief financial officer directly owned 214,847 shares of the company’s stock, valued at $5,377,620.41. The trade was a 3.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Parth Mehrotra sold 105,439 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $22.55, for a total transaction of $2,377,649.45. Following the sale, the chief executive officer directly owned 450,004 shares in the company, valued at $10,147,590.20. This trade represents a 18.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 156,535 shares of company stock worth $3,586,903. 5.70% of the stock is owned by insiders.
Privia Health Group Company Profile
Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.
Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.
Featured Stories
- Five stocks we like better than Privia Health Group
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. (NASDAQ:PRVA – Free Report).
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
